Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group-Reference-Cited by-同舟云学术

Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Published:2018-02-15 Issue:5 Volume:117 Page:868-878
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Merath Katiuscha¹,Bagante Fabio¹²,Beal Eliza W.¹,Lopez-Aguiar Alexandra G.³,Poultsides George⁴,Makris Eleftherios⁴,Rocha Flavio⁵,Kanji Zaheer⁵,Weber Sharon⁶,Fisher Alexander⁶,Fields Ryan⁷,Krasnick Bradley A.⁷,Idrees Kamran⁸,Smith Paula M.⁸,Cho Cliff⁹,Beems Megan⁹,Schmidt Carl R.¹^ORCID,Dillhoff Mary¹,Maithel Shishir K³,Pawlik Timothy M.¹^ORCID

Affiliation:

1. Division of Surgical Oncology; The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center; Columbus Ohio

2. Department of Surgery; University of Verona; Verona Italy

3. Division of Surgical Oncology; Department of Surgery; Winship Cancer Institute; Emory University; Atlanta Georgia

4. Department of Surgery; Stanford University; Palo Alto California

5. Department of Surgery; Virginia Mason Medical Center; Seattle Washington

6. Department of Surgery; University of Wisconsin School of Medicine and Public Health; Madison Wisconsin

7. Department of Surgery; Washington University School of Medicine; St. Louis Wisconsin

8. Division of Surgical Oncology; Department of Surgery; Vanderbilt University; Nashville Tennessee

9. Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery; Department of Surgery; University of Michigan; Ann Arbor Wisconsin

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.24985/fullpdf

Reference51 articles.

1. Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria;Sandvik;Br J Surg,2016

2. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature;Fraenkel;Endocr Relat Cancer,2014

3. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

4. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol,2017

5. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes;Hallet;Cancer,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease;Cancers;2024-01-01

2. Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT;Endocrine;2023-09-16

3. A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation;BMC Gastroenterology;2023-07-14

4. Preoperative Prediction of Pancreatic Neuroendocrine Tumor Grade based on 68Ga-DOTATATE PET/CT;2023-07-14

5. Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors;Expert Review of Anticancer Therapy;2023-05-15